Sylvain Lamure

14PUBLICATIONS
187CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCell development, proliferation and deathHaematologyMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Apr 14, 2023
Frontal Intermittent Rhythmic Delta Activity Is a Useful Diagnostic Tool of Neurotoxicity After CAR T-Cell Infusion.

Sophie Huby, Philippe Gelisse, Jean-Jacques Tudesq

|Apr 14, 2023
Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post-CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey.

Jaap A van Doesum, Jon Salmanton-García, Francesco Marchesi

|Feb 03, 2023
Arginine metabolism regulates human erythroid differentiation through hypusination of eIF5A.

Pedro Gonzalez-Menendez, Ira Phadke, Meagan E Olive

|Sep 20, 2022
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey.

Livio Pagano, Jon Salmanton-García, Francesco Marchesi

|Jun 15, 2022
Outcome of infection with omicron SARS-CoV-2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report.

Ola Blennow, Jon Salmanton-García, Piotr Nowak

|May 02, 2022
COVID-19 and hairy-cell leukemia: an EPICOVIDEHA survey.

Sylvain Lamure, Jon Salmanton-García, Elena Robin-Marieton

Pageof 3